PROCLAIM Clinical Trial

A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Examine the Effects of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects with Advanced Chronic Congestive Heart Failure

Principal Investigator:

Alex Adler MD, Cardiologist/ Heart Failure Specialist
Methodist Heart, Lung and Vascular Institute

For More Information Contact:

Sue Copp, MS, RN
(309) 672-4674
suecopp@mmci.org

This study is now closed to enrollment.